| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/30/2007 | EP0914605B1 Molecular model for vla-4 inhibitors |
| 05/30/2007 | CN1972956A Novel compounds as inhibitors of hepatitis c virus NS3 serine protease |
| 05/30/2007 | CN1972937A Neuropeptide receptor modulators |
| 05/30/2007 | CN1972936A Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure |
| 05/30/2007 | CN1972932A Compounds and methods for treating dyslipidemia |
| 05/30/2007 | CN1972923A Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 05/30/2007 | CN1972922A 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
| 05/30/2007 | CN1970552A Substituted[1,3,5] triazine compound, its preparing process and its application |
| 05/30/2007 | CN1318031C Compositions containing benzoxazinone and nucleoside like materials |
| 05/29/2007 | US7223788 therapy for eating disorders, anorexigenic agents, antidiabetic agents, reducing weight in mammals, circadian rhythm disease, psychological disorders |
| 05/29/2007 | US7223785 Viral polymerase inhibitors |
| 05/29/2007 | US7223782 Pyrazole-amides and -sulfonamides |
| 05/29/2007 | US7223776 Compounds with anti-bacterial activity |
| 05/29/2007 | US7223759 N-(4-(2,2-difluoro-benzo(1,3)dioxol-5-ylcarbamoyl)-3-hydroxy-phenyl)-4,6-Bis-((3R,5S)-3,5-diamino-piperidin-1-yl)-(1,3,5)triazine-2-amine for example; Gram-positive and Gram-negative strains; retains potency against common antibiotic resistant strains |
| 05/29/2007 | US7223757 Such as (S)-4-[2-(3-Chloro-phenyl)-2-hydroxy-ethylamino]-3-{6-[4-(2-methoxy-ethyl)-piperazin-1-yl]-4-methyl-1H-benzimidazol-2-yl}-1H-pyridin-2-one bis hydrochloride; anticancer agents; antiproliferative agents |
| 05/29/2007 | US7223738 Inhibitors of Akt activity |
| 05/29/2007 | US7223484 2,1,3-benzothiadiazoles for use as electronic active components |
| 05/29/2007 | CA2190659C Taxoids, preparation and pharmaceutical compositions containing them |
| 05/24/2007 | WO2007059299A1 Aminopyrimidines useful as kinase inhibitors |
| 05/24/2007 | WO2007059157A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | WO2007058602A2 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer’s disease, neurodegeneration and dementia. |
| 05/24/2007 | WO2007058482A1 Novel inhibitors of protein kinase |
| 05/24/2007 | WO2007058392A1 Heterocyclic compound and medicinal application thereof |
| 05/24/2007 | WO2007057128A1 Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 05/24/2007 | WO2007057093A1 3, 6-dihydro-2-oxo-6h-(1,3,4)thiadiazine derivatives |
| 05/24/2007 | WO2007057092A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h-[1,3,4]thiadiazines |
| 05/24/2007 | WO2007027527A3 Isoindole-imide compounds and compositions comprising and methods of using the same |
| 05/24/2007 | WO2007016392A3 Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors |
| 05/24/2007 | WO2006042150A8 Diaminoalkane aspartic protease inhibitors |
| 05/24/2007 | US20070117850 substituted or unsubstituted 2-pyridyl moiety and a pyrozole ring substituted at 4 position with pyridine ring; inhibits the TGF-beta signaling pathway; anticancer, antifibrotic, antitumor, and antiproliferative agents |
| 05/24/2007 | US20070117845 2-Pyridinylethylcarboxamide derivatives and their use as fungicides |
| 05/24/2007 | US20070117843 Quinoline inhibitors of cGMP phosphodiesterase |
| 05/24/2007 | US20070117820 1-([3-Chloro-5-trifluoromethylpyridinyl-2-yl]piperidin-4-yl)-3-(1-methyl-isoquinolin--5-yl)-urea hydrochloride; capsaicin receptor antagonist; calcium level blocker; lower fluorescence; neuropathic, postrheumatoid, osteoarthritic, back, cancer pain, neuralgia, migraine, neuropathies, diabetic neuropathy |
| 05/24/2007 | US20070117812 3,5-Difluoro-2-pyridinecarboxamidine; intermediate for preparing dihydropyrimidines for the treatment and prophylaxis of hepatitis B |
| 05/24/2007 | US20070117810 Reduction with sodium borohydride; lower content of chloroketone and impurity in final product |
| 05/24/2007 | US20070117808 Substituted Cycloalkylpyrrolones As Allosteric Modulators Of Glucokinase |
| 05/24/2007 | US20070117795 Methods and compositions of novel triazine compounds |
| 05/24/2007 | US20070117760 such as N-[5-({[5-({[3-(Dimethylamino)propyl]amino}carbonyl)-1-methyl-1H-pyrrol3-yl]amino}carbonyl)-1-isopropyl-1-H-pyrrol-3-yl]-4-[(3,3-dimethylbutanoyl)amino]-1-methyl-1H-pyrrole-2-carboxamide; oligopeptides; competitive binding |
| 05/24/2007 | US20070113727 Wireless microphone communication system |
| 05/24/2007 | CA2630680A1 Novel 2-amino-imidazole-4-one compounds and their use in the manufacture of a medicament to be used in the treatment of cognitive impairment, alzheimer~s disease, neurodegeneration and dementia. |
| 05/24/2007 | CA2630203A1 3,6-dihydro-2-oxo-6h-1,3,4-thiadiazine derivatives |
| 05/24/2007 | CA2630202A1 Substituted 5-phenyl-3,6-dihydro-2-oxo-6h[1,3,4]-thiadiazines |
| 05/24/2007 | CA2629814A1 Bisamide inhibitors of hedgehog signaling |
| 05/24/2007 | CA2629781A1 Aminopyrimidines useful as kinase inhibitors |
| 05/24/2007 | CA2628461A1 Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors |
| 05/24/2007 | CA2628145A1 Novel dual-use peptidase inhibitors as prodrugs for a therapy of inflammatory and other disorders |
| 05/23/2007 | EP1787990A2 A process for the preparation of ziprasidone |
| 05/23/2007 | EP1787984A2 Azacyclic compounds for use in the treatment of serotonin related diseases |
| 05/23/2007 | EP1786808A1 Method for the preparation of rosiglitazone |
| 05/23/2007 | EP1786807A1 Heterocyclic antiviral compounds |
| 05/23/2007 | EP1786779A1 4-arylazo-3,5-diamino-pyrazole compounds and use thereof |
| 05/23/2007 | EP1786775A1 Dimeric piperidine derivates |
| 05/23/2007 | EP1651641B1 Nicotinamide derivatives useful as pde4 inhibitors |
| 05/23/2007 | EP1560576A4 Synthesis of oligomeric epicatechin and catechin-derived procyanidins |
| 05/23/2007 | EP1423384B1 Pyridine derivatives as raf kinase inhibitors |
| 05/23/2007 | EP1370550B1 Quinolyl propyl piperidine derivatives, the preparation thereof and compositions containing same |
| 05/23/2007 | EP1369419B1 N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same |
| 05/23/2007 | EP1265921B1 Charged compounds comprising a nucleic acid binding moiety and uses therefor |
| 05/23/2007 | EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same |
| 05/23/2007 | CN1969205A 滤光片及花青化合物 Filters and anthocyanin compounds |
| 05/23/2007 | CN1968949A Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 05/23/2007 | CN1968947A Heterocyclic condensed compounds useful as antidiuretic agents |
| 05/23/2007 | CN1968929A Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments |
| 05/23/2007 | CN1317279C 3(2H)-pyridazinone derivative and its preparing process and application |
| 05/23/2007 | CN1317278C Heterocyclic compounds and their use as medicines |
| 05/23/2007 | CN1317274C 1-phenyl-2-heteroaryl-substituted benzimdazole derivatives, their use for the production of pharmaceutical agents as well as pharmaceutical preparations that contain these derivatives |
| 05/22/2007 | US7220865 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal |
| 05/22/2007 | US7220864 Peroxisome proliferator activator controller; dietetics; antidiabetic agents; cardiovascular disorders; antidiabetic agents; hypoglycemic agents; antilipemic agenst |
| 05/22/2007 | US7220856 Substituted quinoline CCR5 receptor antagonists |
| 05/22/2007 | US7220781 Meta-benzamidine derivatives as serine protease inhibitors |
| 05/22/2007 | US7220773 Heterocylic amines used as antidiabetic or hyperglycemic agents |
| 05/22/2007 | US7220771 Jun n-terminal kinase inhibitors |
| 05/22/2007 | US7220768 Prevention reproduction of herpes virus |
| 05/22/2007 | US7220765 have a good affinity for certain subtypes of somatostatin receptors and have useful pharmacological properties |
| 05/22/2007 | US7220760 1-carbonyl-4-carbonylaminotetrahydroquinoline derivatives; especially treating asthma and allergic rhinitis |
| 05/22/2007 | US7220748 Administering, to a patient in need of such treatment, an effective amount of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine or a salt thereof |
| 05/22/2007 | US7220744 Monocyclic substituted phenyl methanones |
| 05/22/2007 | US7220736 Pyrimidine compounds |
| 05/22/2007 | US7220735 And aza- and diaza-derivatives thereof; especially treating allergy or nasal congestion |
| 05/22/2007 | CA2276694C New fatty acid derivatives |
| 05/22/2007 | CA2241466C Pharmaceutical composition containing angiotensin ii antagonist |
| 05/22/2007 | CA2241263C N-arylsulfilimine compounds and their use as catalysts in the preparation of n-arylarylsulfonamide compounds |
| 05/18/2007 | WO2007056366A2 Compounds and compositions as ppar modulators |
| 05/18/2007 | WO2007056228A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/18/2007 | WO2007056220A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/18/2007 | WO2007056099A2 Inhibitors of ion channels |
| 05/18/2007 | WO2007056021A2 5-lipoxygenase-activating protein (flap) inhibitors |
| 05/18/2007 | WO2007055183A1 Benzene derivative or salt thereof |
| 05/18/2007 | WO2007054480A1 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the trpv1 receptor |
| 05/18/2007 | WO2007054474A1 2-(benzimidazol-1-yl)-n-(4-phenylthiazol-2-yl) acetamide derivatives useful in treatment of trpv1 related disorders |
| 05/18/2007 | WO2007054470A1 Use of rylene derivatives as photosensitizers in solar cells |
| 05/18/2007 | WO2007054357A1 Thiazole analogues and uses thereof |
| 05/18/2007 | WO2007054292A2 Azonafide derivatives, methods for their production and pharmaceutical compositions therefrom |
| 05/18/2007 | WO2007029037A3 Class iia histone deacetylase (hdac) substrate |
| 05/18/2007 | WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007029035A3 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 05/18/2007 | WO2007028083A3 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/18/2007 | WO2007002254A3 Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met |
| 05/18/2007 | WO2006138259A3 Chemokine receptor binding compounds |
| 05/18/2007 | CA2629770A1 Thiazole analogues and uses thereof |